The therapeutic value of targeting inflammation in gastrointestinal cancers

Beicheng Sun; Michael Karin

doi:10.1016/j.tips.2014.04.011

Related publications

Article2025

Exploring the role of miR-221/222 in gastrointestinal cancers: implications for innovative therapeutic strategies

Maud M. Morshedi, Seyed Pouya Taghavi, Ghazaleh Pourali, Fatemeh Ravaei, Arash Raisi, Ali Arjmand, Sahar Ahmadi Asouri, Michael R Hamblin, Neda Rahimian, Mahmood Khaksary Mahabady, Maryam Mahjoubin‐Tehran, Hamed Mirzaei

Editorial Material2017

Editorial: Regulation of Inflammation, Its Resolution and Therapeutic Targeting

Mariagrazia Uguccioni, Mauro Martins Teixeira, Massimo Locati, Alberto Mantovani

Article2019

Circular RNAs and gastrointestinal cancers: Epigenetic regulators with a prognostic and therapeutic role

Parisa Naeli, Mohammad Hossein Pourhanifeh, Mohammad Reza Karimzadeh, Zahra Shabaninejad, Ahmad Movahedpour, Hossein Tarrahimofrad, Hamid Reza Mirzaei, Hassan Hassani Bafrani, Amir Savardashtaki, Hamed Mirzaei, Michael R Hamblin

Article2022

Application of Quercetin in the Treatment of Gastrointestinal Cancers

Seyed Mohammad Ali Mirazimi, Fatemeh Dashti, Mohammad Tobeiha, Ali Shahini, Raha Jafari, Mehrad Khoddami, Amirhossein Sheida, Parastoo EsnaAshari, Amir Hossein Aflatoonian, Fateme Elikaii, Melika Sadat Zakeri, Michael R Hamblin, Mohammad Aghajani, Minoodokht Bavarsadkarimi, Hamed Mirzaei

Letter2007

Severe gastrointestinal vasculitis in Henoch-Schoenlein purpura: pathophysiologic mechanisms, the diagnostic value of factor XIII, and therapeutic options

Jae Il Shin, Jae Seung Lee